
TSE:L
This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is recognized as a dominant player in the Canadian grocery and pharmacy sector, benefiting from strong brand loyalty and private label offerings. Despite its robust performance, experts express concerns regarding its valuation, with some calling for caution due to the perception of shrinking growth potential and increased competition from retailers like Walmart and Costco. While some analysts view Loblaw as a defensive investment that could provide stability in uncertain economic times, others critique its recent price surges and suggest trimming positions. The company's acquisition of Shoppers Drug Mart is praised for unlocking profitability, though comparisons with ATD highlight some hesitancy among investors. Overall, while Loblaw has shown resilience amid food inflation, market sentiment varies, indicating mixed outlooks on its future performance.
Have gone through a painful restructuring over the past couple of years and are slowly starting to emerge from it. It’s a more competitive business than it used to be. Growth is going to be more cramped because of US entries coming in. Also, input costs are going up which they are unable to pass on to the customers. Valuation is still high. The best the stock is going to do is go up at the rate of growth of earnings, which he thinks is a single digit rate.